[RETRACTED ARTICLE] Analytical Method Development and Validation of Purity in Nimotuzumab Products
Keywords:
Aggregate, Nimotuzumab, Size exclusion chromatographyAbstract
The decision to retract this article was made after the authors identified the presence of certain sensitive that cannot be disclosed or published in any form. We sincerely apologize for any inconvenience this may cause and greatly appreciate your understanding. The authors recognize that the scientific community takes such matters very seriously and wish to extend their apologies to the readers of the journal for not identifying this issue during the submission and review process.
References
Ruei-Min Lu, Yu-Chyi Hwang, I-Ju Liu, Chi-Chiu Lee, Han-Zen Tsai, Hsin-Jung Li and Han-Chung
Wu. Development of therapeutic antibodies for the treatment of diseases. Journal of Biomedical
Science. 27, Article number: 1 (2020).
Yunyu (Linda) Yi and Li Zang. Protein aggregation and its inhibition in bio-pharmaceutics. Int J
Pharm. 289 (1-2): 1-30.
TheraCIM Nimotuzumab Injection solution. http://www.theracim-nimotuzumab.com/wp- content/uploads/2018/09/Insert-Theracim-Thailand.pdf. Accessed on 20/7/2022.
International Conference on Harmonisation (ICH) of Technical Requirements for Registration of
Pharmaceuticals for Human Use. Validation of Analytical Procedures: Text and Methodology
Q2R (1), November 2005.
Appendix F: Guidelines for Standard Method Performance Requirements, AOAC Official Methods of
Analysis. 2016. AOAC INTERNATIONAL, Gaithersburg, MD, USA. [cited on 2020 Oct 14].
Available from: http://www.eoma.aoac.org/app_f.pdf.
Hamrang Z, Rattray NJW, Pluen A. Proteins behaving badly: emerging technologies in profiling
biopharmaceutical aggregation. Trends Biotechnol., 31 (8) (2013), pp. 448-458.
Ratanji KD, Derrick JP, Dearman RJ, Kimber I, Immunogenicity of therapeutic proteins: influence of
aggregation, J. Immunotoxicol. 11 (2). 2014; 99–109.
Moussa EM, Panchal JP, Moorthy BS, Blum JS, Joubert MK, Narhi LO, Topp EM, Immunogenicity of
therapeutic protein aggregates, J. Pharm. Sci. 105 (2). 2016; 417–430.
Hernández-Jiménez J, Martínez-Ortega A, Salmerón-García A, Cabeza J, Prados JC, Ortíz R, Navas N
Study of aggregation in therapeutic monoclonal antibodies subjected to stress and long-term
stability tests by analyzing size exclusion liquid chromatographic profiles, International Journal
of Biological Macromolecules, 118 (A), 2018; 511-524
Tan Z, Ehamparanathan V, Ren T, Tang P, Hoffman L, Kuang J et. al. On-column disulfide bond
formation of monoclonal antibodies during Protein A chromatography eliminates low molecular
weight species and rescues reduced antibodies, mAbs, 12.2020:1.
Sepax Technologies, Inc. User Manual. UM001, Ver.20210624. Available from: https://www.sepax-
tech.com/usermanual/UserManual_TweenTrap.pdf. [Accessed on 10 Jan 2022].
Downloads
Published
Issue
Section
License
Copyright (c) 2025 International Journal of Public Health and Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
If the manuscript is accepted for publication, copyright of the article shall be assigned to the IJPHS. After acceptance of a manuscript, the authors will be requested to complete a copyright transfer agreement form
